Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Clemence J. Belle"'
Autor:
Sandra Brosda, Lauren G. Aoude, Vanessa F. Bonazzi, Kalpana Patel, James M. Lonie, Clemence J. Belle, Felicity Newell, Lambros T. Koufariotis, Venkateswar Addala, Marjan M. Naeini, AGITG DOCTOR Investigators, John V. Pearson, Lutz Krause, Nicola Waddell, Andrew P. Barbour
Publikováno v:
Genome Medicine, Vol 16, Iss 1, Pp 1-16 (2024)
Abstract Background Oesophageal adenocarcinoma (OAC) is a highly heterogeneous cancer with poor survival. Standard curative treatment is chemotherapy with or without radiotherapy followed by oesophagectomy. Genomic heterogeneity is a feature of OAC a
Externí odkaz:
https://doaj.org/article/43ba55869131407abd9450bd4e269118
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The poor treatment response of oesophageal adenocarcinoma (OAC) leads to low survival rates. Its increasing incidence makes finding more effective treatment a priority. Recent treatment improvements can be attributed to the inclusion of the tumour mi
Externí odkaz:
https://doaj.org/article/001c423e408048f5aaa02ae5683aa6b5
Autor:
Michael MacManus, John F. Seymour, Stephen H. Kazakoff, Muhammed B. Sabdia, Clemence J Belle, Joshua W.D. Tobin, Lilia Merida de Long, Jay Gunawardana, Maher K. Gandhi, Ann-Marie Patch, Soi Cheng Law, Hennes Tsang, Ella R. Thompson, Karthik Nath, Colm Keane, Piers Blombery
Publikováno v:
Blood. 136:37-38
Neoantigens are generated by mutations acquired in malignant cells. To be immunogenic, neoantigen peptides must be processed and then presented by HLA molecules on the tumor cell surface to evoke a T cell response. Emerging evidence suggests neoantig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8bcde17e1ab6e39f46e01e61a93a5aba
https://doi.org/10.1182/blood-2020-135954
https://doi.org/10.1182/blood-2020-135954